U.S. Health Secretary Robert F. Kennedy Jr. reignited vaccine controversy this week by repeating debunked claims about the MMR (Measles, Mumps, Rubella) vaccine during a growing measles outbreak, one of the worst in 25 years. Kennedy alleged that the vaccine contains cells from aborted fetuses and questioned the efficacy of the mumps component, sparking backlash from medical experts.
The outbreak, centered in a Mennonite community in Texas, has spread to Oklahoma, Kansas, and New Mexico, infecting hundreds and killing two children. Scientists warn the U.S. may lose its measles elimination status, achieved in 2000, if vaccination rates continue to decline.
Kennedy, long known for promoting vaccine skepticism, claimed in a News Nation interview that religious groups avoid the MMR vaccine due to "aborted fetus debris." However, experts clarified that while the rubella component is produced using a fetal cell line from a 1960s abortion, no actual fetal cells are present in the final vaccine. These lab-grown cells have been replicated for decades and are filtered out during production, leaving only a purified, weakened virus.
According to Dr. Miriam Laufer from the University of Maryland and Dr. Paulo Verardi from the University of Connecticut, any DNA remnants in the final vaccine are negligible—measured in billionths of a gram.
Kennedy also said the mumps portion of the vaccine “doesn’t work” and lacked proper safety testing. However, the CDC reports that two doses of MMR provide about 86% protection against mumps. While immunity may wane over time, vaccinated individuals typically experience milder symptoms if infected.
The Department of Health and Human Services declined to comment on Kennedy’s statements, which many experts say undermine public trust in proven vaccine science.


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Trump Rejects Putin’s New START Extension Offer, Raising Fears of a New Nuclear Arms Race
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Trump Says “Very Good Talks” Underway on Russia-Ukraine War as Peace Efforts Continue
New York Legalizes Medical Aid in Dying for Terminally Ill Patients
China Warns US Arms Sales to Taiwan Could Disrupt Trump’s Planned Visit
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
U.S. Announces Additional $6 Million in Humanitarian Aid to Cuba Amid Oil Sanctions and Fuel Shortages
Norway Opens Corruption Probe Into Former PM and Nobel Committee Chair Thorbjoern Jagland Over Epstein Links
Trump Signs “America First Arms Transfer Strategy” to Prioritize U.S. Weapons Sales
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Iran–U.S. Nuclear Talks in Oman Face Major Hurdles Amid Rising Regional Tensions
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash 



